The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements
Abstract
The induction of phase II detoxifying enzymes is an important defense mechanism against intake of xenobiotics. While this group of enzymes is believed to be under the transcriptional control of antioxidant response elements (AREs), this contention is experimentally unconfirmed. Since the ARE resembles the binding sequence of erythroid transcription factor NF-E2, we investigated the possibility that the phase II enzyme genes might be regulated by transcription factors that also bind to the NF-E2 sequence. The expression profiles of a number of transcription factors suggest that an Nrf2/small Maf heterodimer is the most likely candidate to fulfill this role in vivo. To directly test these questions, we disrupted the murine nrf2 gene in vivo. While the expression of phase II enzymes (e.g., glutathione S-transferase and NAD(P)H: quinone oxidoreductase) was markedly induced by a phenolic antioxidant in vivo in both wild type and heterozygous mutant mice, the induction was largely eliminated in the liver and intestine of homozygous nrf2-mutant mice. Nrf2 was found to bind to the ARE with high affinity only as a heterodimer with a small Maf protein, suggesting that Nrf2/small Maf activates gene expression directly through the ARE. These results demonstrate that Nrf2 is essential for the transcriptional induction of phase II enzymes and the presence of a coordinate transcriptional regulatory mechanism for phase II enzyme genes. The nrf2-deficient mice may prove to be a very useful model for the in vivo analysis of chemical carcinogenesis and resistance to anti-cancer drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using in vivo studies in mice, Itoh et al. discovered that the induction of phase II enzymes through the ARE is mediated by a protein transcription factor called Nrf2 [44] (Figure 2).”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [44]
In the citing paper
“Within the nucleus, Nrf2 cannot bind to the ARE as a monomer and must heterodimerize with the small Maf protein (sMaf) family (MafF, MafG, MafK) for transcriptional activation of antioxidant genes [44].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [44]
In the citing paper
“Antioxidant genes regulated by nuclear factor (erythroid-derived 2)-like 2 (Nrf2) possess functional roles to limit microglial inflammation.”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [167]
In the citing paper
“Nrf2 is a basic leucine zipper transcription factor that upregulates genes via interaction with an antioxidant response element (ARE), e.g., genes encoding NADH-quinone oxidoreductase 1 (NQO1) and glutathione-S-transferases (GSTs) [167].”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [167]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Glutathione Transferases—Structure and Catalytic Activit
Mannervik, B., Danielson, U. H., & KETTERER, B. (1988) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238809088226 · Cited by 1,759
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Rushmore, T. H., Morton, M. R., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99004-6 · Cited by 1,464
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
Chasseaud, L. F. (1979) · Advances in cancer research · doi:10.1016/s0065-230x(08)60848-9 · Cited by 1,165
Radjendirane, V., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,034
Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene
Branen, A. L. (1975) · Journal of the American Oil Chemists Society · doi:10.1007/bf02901825 · Cited by 768
Oyake, T., Itoh, K., Motohashi, H., Hayashi, N., Hoshino, H., Nishizawa, M., Yamamoto, M. P., & Igarashi, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6083 · Cited by 656
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Kataoka, 1994, Mol. Cell. Biol., 14, 700
- Chomczynski, 1987, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2 · DOI
- Waxam, 1990, Cancer Res., 50, 6449
Cited by
Sorted by citations
Items 901–1,000 of 1,036
El-Twab, S. M. A., Hussein, O. E., Hozayen, W. G., Bin-Jumah, M. N., & Mahmoud, A. M. (2019) · Inflammation Research · doi:10.1007/s00011-019-01241-z · Cited by 105
Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity
Chowdhury, A., Jahan, N., Adelusi, T. I., & Wang, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105102 · Cited by 107
Current Landscape of NRF2 Biomarkers in Clinical Trials
Yagishita, Y., Gatbonton-Schwager, T. N., McCallum, M. L., & Kensler, T. W. (2020) · Antioxidants · doi:10.3390/antiox9080716 · Cited by 114
Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
Bao, L.-J., Jaramillo, M. C., Zhang, Z.-B., Zheng, Y.-X., Yao, M., Zhang, D. D., & Yi, X.-F. (2014) · Europe PMC (PubMed Central) · Cited by 103
Effects of Nrf2 Deficiency on Bone Microarchitecture in an Experimental Model of Osteoporosis
Ibáñez, L., Ferrándiz, M. L., Brines, R., Guede, D., Cuadrado, A., & Alcaraz, M. J. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/726590 · Cited by 104
Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress
Wondrak, G. T., Cabello, C. M., Villeneuve, N. F., Zhang, S., Ley, S., Li, Y., Sun, Z., & Zhang, D. D. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.023 · Cited by 103
Impaired megakaryopoiesis and behavioral defects inmafG-null mutant micePreprint
Shavit, J. A., Motohashi, H., Onodera, K., Akasaka, J.-E., Yamamoto, M. P., & Engel, J. D. (1998) · Genes & Development · doi:10.1101/gad.12.14.2164 · Cited by 104
A PGAM5–KEAP1–Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking
O'Mealey, G. B., Plafker, K. S., Berry, W. L., Janknecht, R., Chan, J. Y., & Plafker, S. M. (2017) · Journal of Cell Science · doi:10.1242/jcs.203216 · Cited by 99
Lallemand, T., Rouahi, M., Swiader, A., Grazide, M.-H., Geoffre, N., Alayrac, P., Recazens, E., Coste, A., Salvayre, R., Nègre‐Salvayre, A., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311208 · Cited by 104
Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance
Tuy, K., Rickenbacker, L., & Hjelmeland, A. B. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101953 · Cited by 107
Toyama, T., Shinkai, Y., Yasutake, A., Uchida, K., Yamamoto, M. P., & Kumagai, Y. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003123 · Cited by 103
Chen, S., Su, Y., & Wang, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.253 · Cited by 105
Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells
Pulkkinen, K. H., Ylä‐Herttuala, S., & Levonen, A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.014 · Cited by 102
Sturm, C., & Wagner, A. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091890 · Cited by 101
Kandeil, M. A., Mohammed, E. T., Hashem, K. S., Aleya, L., & Abdel‐Daim, M. M. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-05514-2 · Cited by 106
Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
Sharifi‐Rad, J., Seidel, V., Izabela, M., Monserrat-Mesquida, M., Sureda, A., Ormazábal, V., Zuñiga, F. A., Shetty, M. S., Pezzani, R., Ydyrys, A., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01109-0 · Cited by 111
Kimura, M., Yamamoto, T., Zhang, J., Itoh, K., Kyo, M., Kamiya, T., Aburatani, H., Katsuoka, F., Kurokawa, H., Tanaka, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706863200 · Cited by 102
Hirotsu, Y., Hataya, N., Katsuoka, F., & Yamamoto, M. P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06706-11 · Cited by 102
Satoh, H., Moriguchi, T., Saigusa, D., Baird, L., Yu, L., Rokutan, H., Igarashi, K., Ebina, M., Shibata, T., & Yamamoto, M. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1584 · Cited by 102
Targeted Deletion of Nrf2 Impairs Lung Development and Oxidant Injury in Neonatal Mice
Cho, H., Houten, B. V., Wang, X., Miller‐DeGraff, L., Fostel, J. M., Gladwell, W., Perrow, L., Panduri, V., Kobzik, L., Yamamoto, M. P., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4288 · Cited by 101
Li, W., Guo, Y., Zhang, C., Wu, R., Yang, Y., Gaspar, J. M., & Kong, A. T. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00413 · Cited by 101
Tian, W., de la Vega, M. R., Schmidlin, C. J., Ooi, A., & Zhang, D. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000428 · Cited by 101
Blockade of Glutathione Metabolism in IDH1 -Mutated Glioma
Tang, X., Fu, X., Liu, Y., Yu, D., Cai, S. J., & Yang, C. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0103 · Cited by 100
Weniger, M. A., Rizzatti, E. G., Pérez‐Galán, P., Liu, D., Wang, Q., Munson, P. J., Raghavachari, N., White, T., Tweito, M. M., Dunleavy, K. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3367 · Cited by 101
Pendyala, S., Moitra, J., Kalari, S. K., Kleeberger, S. R., Zhao, Y., Reddy, S. P., Garcia, J. G. N., & Natarajan, V. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.022 · Cited by 101
Bloom, D. A., Dhakshinamoorthy, S., & Jaiswal, A. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205288 · Cited by 102
Complexity of CNC Transcription Factors As Revealed by Gene Targeting of the Nrf3 Locus
Derjuga, A., Gourley, T. S., Holm, T. M., Heng, H. H. Q., Shivdasani, R. A., Ahmed, R., Andrews, N. C., & Blank, V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3286-3294.2004 · Cited by 100
Mylroie, H., Dumont, O., Bauer, A., Thornton, C. C., Mackey, J., Calay, D., Hamdulay, S., Choo, J. R. E., Boyle, J. J., Samarel, A. M., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv131 · Cited by 100
NRF2, a Key Regulator of Antioxidants with Two Faces towards Cancer
Kim, J., & Keum, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2746457 · Cited by 101
Ma, J., Li, S., Zhu, L., Guo, S., Yi, X., Cui, T., He, Y., Chang, Y., Liu, B., Li, C., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.421 · Cited by 100
Heightman, T. D., Callahan, J. F., Chiarparin, E., Coyle, J. E., Griffiths-Jones, C., Lakdawala, A. S., McMenamin, R. L., Mortenson, P. N., Norton, D., Peakman, T. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00279 · Cited by 104
The intricacies of NRF2 regulation in cancer
Schmidlin, C. J., Shakya, A., Dodson, M. B., Chapman, E., & Zhang, D. D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.016 · Cited by 103
Antioxidative effects of quercetin-glycosides isolated from the flower buds of Tussilago farfara L.
Kim, M.-R., Lee, J. Y., Lee, H.-H., Aryal, D. K., Kim, Y. G., Kim, S. K., Woo, E., & Kang, K. W. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.02.007 · Cited by 100
Suzuki, T., Takagi, Y., Osanai, H., Li, L., TAKEUCHI, M., Katoh, Y., Kobayashi, M., & Yamamoto, M. P. (2005) · Biochemical Journal · doi:10.1042/bj20041860 · Cited by 100
Ali, Z. E., Gerbeix, C., Hémon, P., Esser, P. R., Martin, S. F., Pallardy, M. J., & Kerdine‐Römer, S. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft084 · Cited by 103
Calver, A., Collier, J., Leone, A., Moncada, S., & Vallance, P. J. (1993) · PubMed · Cited by 100
Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases
Nakagami, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7469326 · Cited by 100
Naidu, S. D., Muramatsu, A., Saito, R., Asami, S., Honda, T., Hosoya, T., Itoh, K., Yamamoto, M. P., Suzuki, T., & Dinkova‐Kostova, A. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-26269-9 · Cited by 99
Iranshahy, M., Iranshahi, M., Abtahi, S. R., & Karimi, G. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.07.024 · Cited by 100
Chen, D., Feng, Y., Chen, L., Liu, J., Wang, M., Vaziri, N. D., & Zhao, Y. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.046 · Cited by 99
Oxidative stress in sepsis: a redox redux
Kolls, J. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28111 · Cited by 99
A transcriptional profile of the decidua in preeclampsia
Løset, M., Mundal, S. B., Johnson, M. P., Fenstad, M. H., Freed, K., Lian, I. A., Eide, I. P., Bjørge, L., Blangero, J., Moses, E. K., et al. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.043 · Cited by 99
Palliyaguru, D. L., Chartoumpekis, D. V., Wakabayashi, N., Skoko, J., Yagishita, Y., Singh, S. V., & Kensler, T. W. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.003 · Cited by 99
Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder
Huppke, P., Weißbach, S., Church, J. A., Schnur, R. E., Krusen, M., Dreha‐Kulaczewski, S. F., Kühn‐Velten, W. N., Wolf, A., Huppke, B., Millan, F., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00932-7 · Cited by 97
Regulation of glutathione in inflammation and chronic lung diseases
Rahman, I. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.02.025 · Cited by 98
Role of Lung Maintenance Program in the Heterogeneity of Lung Destruction in Emphysema
Tuder, R. M., Yoshida, T., Fijalkowka, I., Biswal, S. S., & Petrache, I. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-124sf · Cited by 98
Deficiency in Nrf2-GSH Signaling Impairs Type II Cell Growth and Enhances Sensitivity to Oxidants
Reddy, N. M., Kleeberger, S. R., Cho, H., Yamamoto, M. P., Kensler, T. W., Biswal, S. S., & Reddy, S. P. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0004rc · Cited by 98
Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers
Taguchi, K., Hirano, I., Itoh, T., Tanaka, M., Miyajima, A., Suzuki, A., Motohashi, H., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01384-13 · Cited by 98
Cyclopentenone Prostaglandins as Potential Inducers of Phase II Detoxification Enzymes
Kawamoto, Y., Nakamura, Y., Naito, Y., Torii, Y., Kumagai, T., Osawa, T., Ohigashi, H., Satoh, K., Imagawa, M., & Uchida, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11291 · Cited by 98
Cell-Nonautonomous Regulation of Proteostasis in Aging and DiseasePreprint
Morimoto, R. I. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034074 · Cited by 98
Abiko, Y., Miura, T., Phuc, B. H., Shinkai, Y., & Kumagai, Y. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.05.013 · Cited by 98
Yeang, H. X. A., Hamdam, J. M., Al-Huseini, L. M. A., Sethu, S., Djouhri, L., Walsh, J., Kitteringham, N. R., Park, B. K., Goldring, C. E., & Sathish, J. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322420 · Cited by 97
Joo, M. S., Lee, C. G., Koo, J. H., & Kim, S. G. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.427 · Cited by 97
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Jung, B.-J., Yoo, H.-S., Shin, S., Park, Y., & Jeon, S. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.195 · Cited by 104
Wang, R., Luo, Y., Lu, Y., Wang, D., Wang, T., Pu, W., & Wang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4703253 · Cited by 97
Activation of Nrf2–ARE pathway in brain after traumatic brain injury
Yan, W. X., Wang, H., Hu, Z.-G., Wang, Q.-F., & Yin, H.-X. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.060 · Cited by 97
P38-Nrf-2 Signaling Pathway of Oxidative Stress in Mice Caused by Nanoparticulate TiO2
Wang, J., Li, N., Zheng, L., Wang, S., Wang, Y., Zhao, X., Duan, Y., Cui, Y., Zhou, M., Cai, J., et al. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8687-0 · Cited by 97
Smad3–ATF3 signaling mediates TGF-β suppression of genes encoding Phase II detoxifying proteins
Bakin, A. V., Stourman, N. V., Sekhar, K. R., Rinehart, C., Yan, X. S., Meredith, M. J., Arteaga, C. L., & Freeman, M. L. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.033 · Cited by 97
Mao, L., Wang, H., Qiao, L., & Wang, X. (2010) · Mediators of Inflammation · doi:10.1155/2010/238321 · Cited by 97
Escartin, C., Won, S. J., Malgorn, C., Aurégan, G., Berman, A., Chen, P., Déglon, N., Johnson, J. A., Suh, S. W., & Swanson, R. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6577-10.2011 · Cited by 96
Keum, Y., Han, Y., Liew, C. V., Kim, J. H., Xu, C., Yuan, X., Shakarjian, M. P., Chong, S., & Kong, A. T. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9094-2 · Cited by 98
A1M, an extravascular tissue cleaning and housekeeping protein
Åkerström, B., & Gram, M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.025 · Cited by 96
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
Yang, Z., Chen, J.-S., Wen, J., Gao, H., Zheng, B., Qu, C., Liu, K.-L., Zhang, M., Gu, J., Li, J., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0649-3 · Cited by 96
Chhunchha, B., Kubo, E., & Singh, D. P. (2020) · Cells · doi:10.3390/cells9081861 · Cited by 98
Nrf2 deficiency deteriorates diabetic kidney disease in Akita model mice
Liu, Y., Uruno, A., Saito, R., Matsukawa, N., Hishinuma, E., Saigusa, D., Liu, H., & Yamamoto, M. P. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102525 · Cited by 97
Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects.
Karikas, G. A. (2010) · PubMed · Cited by 96
Zhu, H., Jia, Z., Zhang, L., Yamamoto, M. P., Misra, H. P., Trush, M. A., & Li, Y. (2008) · Experimental Biology and Medicine · doi:10.3181/0711-rm-304 · Cited by 98
Role of Nrf2 in Protection against Traumatic Brain Injury in Mice
Jin, W., Wang, H., Yan, W. X., Zhu, L., Hu, Z., Ding, Y., & Tang, K. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0655 · Cited by 100
Rim, J. S., & Kozak, L. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108866200 · Cited by 99
Huang, Y. S., Li, W., & Kong, A. T. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-40 · Cited by 96
Proteasome activation delays aging in vitro and in vivo
Chondrogianni, N., Sakellari, M., Lefaki, M., Papaevgeniou, N., & Gonos, E. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.031 · Cited by 94
Xu, X., Zhang, Y., Li, W., Miao, H., Zhang, H., Zhou, Y., Li, Z., You, Q., Zhao, L., & Guo, Q. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.09.008 · Cited by 95
Quercetin attenuates zymosan-induced arthritis in mice
Guazelli, C. F. S., Staurengo‐Ferrari, L., Zarpelon, A. C., Pinho-Ribeiro, F. A., Ruiz-Miyazawa, K. W., Vicentini, F. T. M. C., Vignoli, J. A., Camilios‐Neto, D., Georgetti, S. R., Baracat, M. M., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.057 · Cited by 99
A Bibliometric Review of the Keap1/Nrf2 Pathway and its Related Antioxidant Compounds
Paunkov, A., Chartoumpekis, D. V., Ziros, P. G., & Sykiotis, G. P. (2019) · Antioxidants · doi:10.3390/antiox8090353 · Cited by 94
Nrf2 reduces allergic asthma in mice through enhanced airway epithelial cytoprotective function
Sussan, T. E., Gajghate, S., Chatterjee, S., Mandke, P., McCormick, S. M., Sudini, K. R., Kumar, S., Breysse, P. N., Diette, G. B., Sidhaye, V. K., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00398.2014 · Cited by 95
Wang, H., Xu, Y., & Zhu, C. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9292-5 · Cited by 95
Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells
Kosaka, K., Mimura, J., Itoh, K., Satoh, T., Shimojo, Y., Kitajima, C., Maruyama, A., Yamamoto, M. P., & Shirasawa, T. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp149 · Cited by 95
Nrf2 target genes are induced under marginal selenium-deficiency
Müller, M. F., Banning, A., Brigelius‐Flohé, R., & Kipp, A. P. (2010) · Genes & Nutrition · doi:10.1007/s12263-010-0168-8 · Cited by 95
Hong, C., Ambrosone, C. B., Ahn, J., Choi, J., McCullough, M. L., Stevens, V. L., Rodriguez, C., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0247 · Cited by 95
Genetic Activation of Nrf2 Protects against Fasting-Induced Oxidative Stress in Livers of Mice
Zhang, Y.-K. J., Wu, K. C., & Klaassen, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059122 · Cited by 94
Myeloid Lineage–Specific Deletion of Antioxidant System Enhances Tumor Metastasis
Hiramoto, K., Satoh, H., Suzuki, T., Moriguchi, T., Pi, J., Shimosegawa, T., & Yamamoto, M. P. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0094 · Cited by 94
Baluchnejadmojarad, T., Kiasalari, Z., Afshin‐Majd, S., Ghasemi, Z., & Roghani, M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.033 · Cited by 98
Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass
Ahn, B., Pharaoh, G. A., Premkumar, P., Huseman, K., Ranjit, R., Kinter, M. T., Szweda, L. I., Kiss, T., Fülöp, G. Á., Tarantini, S., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.04.004 · Cited by 94
The KEAP1-NRF2 System in Healthy Aging and Longevity
Matsumaru, D., & Motohashi, H. (2021) · Antioxidants · doi:10.3390/antiox10121929 · Cited by 103
Exploring the target scope of KEAP1 E3 ligase-based PROTACs
Du, G., Jiang, J., Henning, N. J., Safaee, N., Koide, E., Nowak, R. P., Donovan, K. A., Yoon, H., You, I., Yue, H., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.08.003 · Cited by 97
Stöckel, B., König, J., Nies, A. T., Cui, Y., Brom, M., & KEPPLER, D. O. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01106.x · Cited by 95
Roles Nrf2 Plays in Myeloid Cells and Related Disorders
Kobayashi, E. H., Suzuki, T., & Yamamoto, M. P. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/529219 · Cited by 99
von Otter, M., Landgren, S., Nilsson, S., Zetterberg, M., Celojevic, D., Bergström, P., Minthon, L., Bogdanović, N., Andreasen, N., Gustafson, D., et al. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.12.007 · Cited by 96
Yano, Y., Ozono, R., Oishi, Y., Kambe, M., Yoshizumi, M., Ishida, T., Omura, S., Oshima, T., & Igarashi, K. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.00979.x · Cited by 94
Regulation of Nrf2, NF-κB, and AP-1 Signaling Pathways by Chemopreventive Agents
Shen, G., Jeong, W., Hu, R., & Kong, A. T. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1648 · Cited by 94
Kratschmar, D. V., Calabrese, D., Walsh, J., Lister, A., Birk, J., Appenzeller‐Herzog, C., Moulin, P., Goldring, C. E., & Odermatt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036774 · Cited by 95
Role of Nrf2 in Host Defense against Influenza Virus in Cigarette Smoke-Exposed Mice
Yageta, Y., Ishii, Y., Morishima, Y., Masuko, H., Ano, S., Yamadori, T., Itoh, K., Takeuchi, K., Yamamoto, M. P., & Hizawa, N. (2011) · Journal of Virology · doi:10.1128/jvi.02456-10 · Cited by 94
Tarumoto, T., Nagai, T., Ohmine, K., Miyoshi, T., Nakamura, M., Kondo, T., Mitsugi, K., Nakano, S., Muroi, K., Komatsu, N., et al. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.007 · Cited by 97
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_9 · Cited by 98
The role of Nrf2 in skeletal muscle contractile and mitochondrial function
Crilly, M. J., Tryon, L. D., Erlich, A. T., & Hood, D. A. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00042.2016 · Cited by 97
The Role of Nrf2: Adipocyte Differentiation, Obesity, and Insulin Resistance
Seo, H.-A., & Lee, I. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/184598 · Cited by 93
NRF2 in Cardiovascular Diseases: a Ray of Hope!
Vashi, R., & Patel, B. M. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10083-8 · Cited by 95
Nrf2 a molecular therapeutic target for Astaxanthin
Kohandel, Z., Farkhondeh, T., Aschner, M., & Samarghandian, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111374 · Cited by 97
Bourgonje, A. R., Klóska, D., Grochot‐Przeczek, A., Feelisch, M., Cuadrado, A., & van Goor, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102603 · Cited by 101
Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis
Hayes, J. D., Naidu, S. D., & Dinkova‐Kostova, A. T. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.12.010 · Cited by 103
Metadata
- Authors
- Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., & Nabeshima, Y.-I.
- Affiliations
- University of Tsukuba (JP)
- Japan Science and Technology Agency (JP)
- Tohoku University (JP)
- Hirosaki University (JP)
- National Institute of Neuroscience (JP)
- Corresponding author
- Yamamoto, Masayuki
- ORCID
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 1997-07
- Volume
- 236
- Issue
- 2
- Pages
- 313-322
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W1991631628
- Cited by
- 3,999
- References
- 49
- Citations by year
- 2026: 138 · 2025: 154 · 2024: 165 · 2023: 187 · 2022: 196 · 2021: 222 · 2020: 257 · 2019: 224 · 2018: 197 · 2017: 236 · 2016: 227 · 2015: 194 · 2014: 169 · 2013: 206 · 2012: 160
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (RFTF96I00202)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- Nrf2, heterodimer, antioxidant response element, phase II enzymes, transcriptional regulation, Nrf2 knockout mice, glutathione S-transferase, NAD(P)H:quinone oxidoreductase, NF-E2, phenolic antioxidants, xenobiotic metabolism, chemical carcinogenesis, drug resistance
- MeSH terms
- Animals, Binding Sites, Butylated Hydroxyanisole, DNA-Binding Proteins, Glutathione Transferase, Heterozygote, Homozygote, Intestines, Liver, Male, Promoter Regions, Genetic, Quinone Reductases, Transcription Factors, Xenobiotics, Trans-Activators, Gene Expression Regulation, Enzymologic, Mice, Knockout, DNA Adducts, Dimerization, NF-E2-Related Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review